Elucidating the Mechanism of Action of Pregabalin: α 2 δ as a Therapeutic Target in Anxiety

ISSN： 1172-7047

Source： CNS Drugs, Vol.26, Iss.8, 2012-08, pp. : 637-648

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of pharmacological agents in elucidating the mechanism of insulin action

By Srivastava A.K.

Trends in Pharmacological Sciences, Vol. 19, Iss. 6, 1998-06 ,pp. : 205-209

Elsevier

Access to resources Recommend Favorite

Neuroprotective and Abstinence-Promoting Effects of Acamprosate: Elucidating the Mechanism of Action

By Philippe De Witte

CNS Drugs, Vol. 19, Iss. 6, 2005-01 ,pp. : 517-537

Adis International

Access to resources Recommend Favorite

Ceramide Kinase and the Ceramide-1-Phosphate/cPLA2 Interaction as a Therapeutic Target

Current Drug Targets, Vol. 9, Iss. 8, 2008-08 ,pp. : 674-682

Bentham Science Publishers

Access to resources Recommend Favorite

Pregabalin: In the Treatment of Generalised Anxiety Disorder

By Frampton James E. Foster Rachel H.

CNS Drugs, Vol. 20, Iss. 8, 2006-01 ,pp. : 685-693

Adis International

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor β/δ as a therapeutic target for metabolic diseases

By Bedu Elodie Wahli Walter Desvergne Béatrice

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 861-873

Informa Healthcare

Access to resources Recommend Favorite